Investors sentiment increased to 1.97 in Q1 2019. Its up 0.85, from 1.12 in 2018Q4. It improved, as 17 investors sold Insulet Corporation shares while 53 reduced holdings. 53 funds opened positions while 85 raised stakes. 67.79 million shares or 6.58% more from 63.61 million shares in 2018Q4 were reported.
Mackay Shields Ltd Liability Corp stated it has 920,000 shares. Principal Financial Grp Inc holds 0% in Insulet Corporation (NASDAQ:PODD) or 11,650 shares. Shaker Invests Ltd Llc Oh has 47,415 shares for 3.12% of their portfolio. Moreover, Bnp Paribas Arbitrage Sa has 0% invested in Insulet Corporation (NASDAQ:PODD) for 3,232 shares. Point72 Asset Mngmt Lp accumulated 117,698 shares. Champlain Investment Ptnrs Limited Liability Company holds 617,790 shares or 0.51% of its portfolio. D E Shaw holds 855,676 shares or 0.11% of its portfolio. 34,119 are owned by Daruma Management Ltd Liability. Granahan Inv Ma owns 81,357 shares. Nuveen Asset Mngmt Ltd Liability Co holds 0.01% of its portfolio in Insulet Corporation (NASDAQ:PODD) for 19,413 shares. Sei Invests has invested 0.01% in Insulet Corporation (NASDAQ:PODD). Arrowmark Colorado Holdg Lc reported 613,378 shares. Primecap Management Ca invested in 4.92M shares or 0.34% of the stock. 394,751 are held by Bank Of America De. Pnc Fincl Ser Gp has 1,448 shares.
Since January 31, 2019, it had 0 buys, and 2 selling transactions for $937,720 activity.
Analysts expect Insulet Corporation (NASDAQ:PODD) to report $0.03 EPS on August, 1.They anticipate $0.06 EPS change or 200.00 % from last quarter’s $-0.03 EPS. PODD’s profit would be $1.79M giving it 998.75 P/E if the $0.03 EPS is correct. After having $0.07 EPS previously, Insulet Corporation’s analysts see -57.14 % EPS growth. The stock increased 0.22% or $0.26 during the last trading session, reaching $119.85. About 211,546 shares traded. Insulet Corporation (NASDAQ:PODD) has risen 19.34% since July 6, 2018 and is uptrending. It has outperformed by 14.91% the S&P500.
Insulet Corporation (NASDAQ:PODD) Ratings Coverage
Among 6 analysts covering Insulet Corp (NASDAQ:PODD), 4 have Buy rating, 0 Sell and 2 Hold. Therefore 67% are positive. Insulet Corp had 15 analyst reports since February 19, 2019 according to SRatingsIntel. The company was maintained on Thursday, June 27 by JP Morgan. The rating was maintained by Oppenheimer with “Hold” on Tuesday, February 26. The firm earned “Buy” rating on Tuesday, February 26 by Robert W. Baird. Canaccord Genuity maintained Insulet Corporation (NASDAQ:PODD) rating on Tuesday, February 19. Canaccord Genuity has “Buy” rating and $100 target. The firm has “Buy” rating by Northland Capital given on Tuesday, February 26. On Thursday, June 13 the stock rating was maintained by UBS with “Buy”.
Insulet Corporation, a medical device company, develops, makes, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company has market cap of $7.15 billion. The firm offers Omnipod Insulin Management System , which consists of the OmniPod, an easy-to-use continuous insulin delivery system; and Personal Diabetes Manager, a handheld wireless device. It has a 532.67 P/E ratio. It also customizes the Omnipod System technology platform for the delivery of subcutaneous drugs across various therapeutic areas.
More notable recent Insulet Corporation (NASDAQ:PODD) news were published by: Nasdaq.com which released: “Why the Earnings Surprise Streak Could Continue for Insulet (PODD) – Nasdaq” on April 29, 2019, also Seekingalpha.com with their article: “Insulet Q1 top line up 29% on Q1 beat; guidance raised – Seeking Alpha” published on May 02, 2019, Nasdaq.com published: “Insulet (PODD) Beats Earnings and Revenue Estimates in Q1 – Nasdaq” on May 03, 2019. More interesting news about Insulet Corporation (NASDAQ:PODD) were released by: Seekingalpha.com and their article: “Stocks To Watch: Walmart’s 5260, Computex And Healthcare Headwinds – Seeking Alpha” published on May 25, 2019 as well as Fool.com‘s news article titled: “3 Top Healthcare Stocks to Buy in March – The Motley Fool” with publication date: March 16, 2019.
Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.